Novocure stock surged after the Food and Drug Administration approved its Optune Pax product, which delivers tumor treating ...
AI-assisted drug discovery isn’t just science fiction anymore, especially as biotechnology and biopharma firms embrace the AI ...
The U.S. biotechnology market enters 2026 as the largest global biotech market, with an estimated size of $552.39 billion in 2023, and is projected to grow to $1.24 trillion by 2030.
Biotech investors often chase early-stage companies in the hope that a single breakthrough trial will deliver massive returns ...
Four drug companies — Agomab Therapeutics, Eikon Therapeutics, Spyglass Pharma, and Veradermics — went public this week, ...
Biotech stocks are gaining momentum as weight-loss drugs, pipeline depth and clinical data drive renewed growth optimism.
Artificial intelligence (AI) isn't the only industry with explosive growth potential.
The volatile biotech industry has put up a strong performance in 2025 despite the uncertain macroeconomic environment. While the tariff saga hit the pharma/biotech industry earlier in the year, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results